AMY CLARK: Open Payments
NPI 1548631575 · GREENVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$465 in 23 payments from 12 companies in 2025. Trend: 2023 $812 · 2024 $899 · 2025 $465
Food & beverage: $465
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $83 |
| Gilead Sciences, Inc. | 3 | $67 |
| Amgen Inc. | 3 | $50 |
| Novo Nordisk Inc | 2 | $49 |
| Corcept Therapeutics | 2 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Exact Sciences Corporation | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
| ABBVIE INC. | 1 | $18 |
| Alkermes, Inc. | 1 | $17 |
Products named: TRELEGY ELLIPTA, Korlym, REXULTI, The Cologuard Plus Collection Kit, OTEZLA, FANAPT, Wegovy, Ozempic.
Industry payments across NC — which companies pay providers there.
